David Shapiro - CEO of B2i Digital
banner
b2idigital.bsky.social
David Shapiro - CEO of B2i Digital
@b2idigital.bsky.social
1.6K followers 11 following 900 posts
B2i Digital executes targeted digital marketing campaigns to generate investor awareness for public companies. David Shapiro is the Founder & CEO. b2idigital.com
Posts Media Videos Starter Packs
Pinned
YY Group Holding (Nasdaq: YYGH) announced that its subsidiary, YY Circle HK, has entered into a manpower support cooperation agreement with a premier Hong Kong hotel group, covering nine of the hotel group’s largest properties under a contract exceeding HKD 35 million.
Unicycive Therapeutics CEO Dr. Shalabh Gupta will join a fireside chat at the Guggenheim Healthcare Innovation Conference on November 10, 2025.
Heidmar’s CEO Pankaj Khanna outlines how the $20 million B. Riley facility supports the company’s growth and strategic flexibility.
Unicycive Therapeutics (Nasdaq: UNCY) announced that CEO Dr. Shalabh Gupta, MD Gupta will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Monday, November 10, 2025, at 3:30 p.m. ET.
Addressing questions about capital structure, Heidmar Inc. Maritime Holdings Corp.'s (NASDAQ: HMR) CEO Pankaj Khanna clarifies the purpose and structure of the company's $20 million B. Riley facility.
Proud to see CORE IR & PR helping make this year’s Spartan Capital Investor Conference a standout event.
Spartan Capital Securities, LLC and B2i Digital are pleased to announce that CORE IR & PR is a Supporting Tier Sponsor of the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.
Unicycive Therapeutics (Nasdaq: UNCY) will present new data at ASN Kidney Week 2025 showing OLC’s potential to greatly reduce pill burden for dialysis patients.
Unicycive Therapeutics (Nasdaq: UNCY) announced the upcoming presentation of new data at ASN Kidney Week 2025 demonstrating that oxylanthanum carbonate (OLC) dramatically reduces pill burden for dialysis patients with hyperphosphatemia.
Unicycive Therapeutics (Nasdaq: UNCY) announced FDA alignment on resolving the single manufacturing deficiency delaying approval of its novel phosphate binder Oxylanthanum Carbonate (OLC).

Unicycive Therapeutics is a B2i Digital Featured Company. View their profile at b2idigital.com/unicycive.
The team at B2i Digital is pleased to recognize a unique collaboration between our own Director of Research, JP Mark, and Professor Sarachek on a comprehensive guide to one of finance’s most challenging and potentially lucrative investment areas.

www.distressedinvestingplaybook.com Code “B2i50”
Blue Lagoon Resources (OTCQB: BLAGF) will present at the Spartan Capital Investor Conference 2025 in New York.
NANO Nuclear Energy Inc. (NASDAQ: NNE) will present at the Spartan Capital Investor Conference 2025 in New York.
NusaTrip (Nasdaq: NUTR) will present at the Spartan Capital Investor Conference 2025 in New York.
Spartan Capital Securities, LLC and B2i Digital are pleased to announce that Blue Lagoon Resources (OTCQB: BLAGF) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.
Spartan Capital Securities, LLC and B2i Digital are pleased to announce that NANO Nuclear Energy Inc. (NASDAQ: NNE) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.
Spartan Capital Securities, LLC and B2i Digital are pleased to announce that Nusatrip (Nasdaq: NUTR) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.
Spartan Capital Securities and B2i Digital are pleased to announce that High Roller Technologies (NYSE American: ROLR) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.

Details and registration at b2idigital.com/spartan-capi....
Spartan Capital Securities and B2i Digital are pleased to announce that Silver X Mining Corp (TSXV: AGX, OTCQB: AGXPF) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.

Details and registration at b2idigital.com/spartan-capi....
Reviva Pharmaceuticals (Nasdaq: RVPH) will present at the Spartan Capital Investor Conference 2025 in New York. Learn more at b2idigital.com/spartan-capi.
b2idigital.com
T-REX Acquisition (OTCQB: TRXA) will present at the Spartan Capital Investor Conference 2025 in New York. Learn more at b2idigital.com/spartan-capi.
b2idigital.com
PetVivo Holdings (OTCQX: PETV) will be presenting at the upcoming Spartan Capital Investor Conference 2025 in New York.